Waldrop: Industry Can Lead on Needed Changes: The Blood-Horse 3/24/16

By: Frank Angst Using the recent accreditation of Fair Grounds Race Course & Slots by the NTRA Safety and Integrity Alliance as an example, NTRA president Alex Waldrop said the industry can work with regulators to improve the sport. Speaking during the Thoroughbred racing committee meeting at the Association of Racing Commissioners International conference March

Backpedaling on Progress: The Bloodhorse 2/9/16

By: Eric Mitchell How many ways can the racing industry find to undermine its own efforts? Sadly, too many. The most recent surfaced last week when the National Horsemen's Benevolent and Protective Association announced it wanted to pay for new research that would set thresholds and withdrawal times for 28 therapeutic medications allowed under the

RMTC STATEMENT ON METHOCARBAMOL (ROBAXIN) THRESHOLD/ TREATMENT PROTOCOLS

NEWS RELEASE October 8, 2015 Contact: Dionne Benson, Executive Director, RMTC, (859) 224-2844 RMTC STATEMENT ON METHOCARBAMOL (ROBAXIN) THRESHOLD/ TREATMENT PROTOCOLS The Kentucky Horse Racing Commission recently suspended trainer Graham Motion for five days and fined him $500 for a medication overage involving the winner Kitten’s Point in Keeneland’s Bewitch Stakes. Kentucky officials determined that Kitten's

Waldrop Q&A: Safety and Integrity Alliance: The Blood-Horse 9/23/15

By Frank Angst In an Aug. 29 Blood-Horse magazine story, National Thoroughbred Racing Association president Alex Waldrop and other industry leaders assessed the work of the NTRA Safety and Integrity Alliance in an article titled "Safety... on a Volunteer Basis." Waldrop participated in an extensive email Q&A with Blood-Horse writer Frank Angst that we thought

Regulators Step Up Push for Drug Uniformity: The Blood-Horse 9/16/15

By Tom LaMarra The Association of Racing Commissioners International is stepping up efforts to get state regulators to fully adopt the National Uniform Medication Program. ARCI chairman Mark Lamberth of the Arkansas State Racing Commission said Sept. 16 he is the process of forming a committee that will address implementation of equine medication reforms. ARCI

Just Do It: The Blood-Horse 8/25/15

By Tom LaMarra In March 2013 eight states in the Mid-Atlantic and Northeast—Delaware, Maryland, Massachusetts, New Jersey, New York, Pennsylvania, Virginia, and West Virginia—announced their intentions to adopt uniform regulations governing equine medication rules and drug testing. The effort, spearheaded by the Thoroughbred Horsemen's Association, which represents owners and trainers in many states in the

California Supports Third-Party Furosemide Administration: The Horse 8/24/15

By Edited Press Release Members of the California Horse Racing Board (CHRB) and California horse racing industry leaders are reaffirming their support for the concept of third-party furosemide (also called Salix or Lasix) administration as part of the National Uniform Medication Program, while offering reassurance that a vote by the board on Aug. 20 to

WVRC Votes to Hire New Drug-Testing Lab: The Blood-Horse 7/28/15

By Tom LaMarra The West Virginia Racing Commission voted July 28 to hire a new equine drug-testing laboratory when the contract with its current lab ends at the end of August. West Virginia is one of four states in the Mid-Atlantic region that employs Truesdail Laboratories of California; the others are Delaware, Maryland, and New

Mid-Atlantic Issues Advisory on Two Drugs: The Blood-Horse 7/21/15

By Tom LaMarra West Virginia has joined other states in the Mid-Atlantic region in posting an advisory regarding use of two therapeutic drugs that can be problematic for horsemen. The advisory stemmed from a Mid-Atlantic regulatory meeting earlier in July at which the progress of the National Uniform Medication Program was discussed. Participants identified two

Learn About Our:

Who We Are:

Sign up to receive RMTC communications:

  • Hidden

Sign up to receive RMTC communications:

  • Hidden